HPV - tratamiento del hpv
DNA HPV TEST IN MEN
Using
molecular pathology techniques, the HPV test, allows us to have a
precise diagnosis of the Human Papillomavirus. The Polymerase Chain
Reaction (PCR) is a painless technique which involves the extraction of
cellular material as it is done in a pap smear but, unlike this, it has
a sensitivity of 100% in the woman and man genital HPV infection. In
other words, there is no possibility of false negatives if the
extraction is correctly performed. This molecular biology technique,
which we prefer and recommend, also gives us the possibility to find
out which type of HPV the patient actually has. The importance of this
lies in the fact that there are tumor viruses, in other words, viruses
related to cancer such as: HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56,
58, 59 and 68, among others. There are other viruses related to benign
warts which may result unsightly or contagious. This technique is also
used in other genital areas such as the vagina, vulva, anus, penis or
other parts of the body, which cannot be contagious, such as the mouth
or areas of the skin near the genitals and different organs where the
HPV infections are less frequent.
Another
currently used technique for detection of the HPV is the
“hybrid-capture” test which gives us the
possibility to obtain information about the human papillomaviruses
connected to genital infection or genital cancer as well as some benign
viruses related to common warts. Unlike PCR, this technique does not
report on the infectious type of viruses and it is only sensitive to
the most frequently found viruses.
The
“hybrid-capture” detects HPV viruses which are
often found in the genitals. These one are classified in: Group I: 6,
11, 42, 43, 44, 53 and 54 called “low-risk” HPV
types and which are not related to cancer; and Group II viruses, also
called of “high-risk”: 16, 18, 31, 33, 35, 39, 45,
51, 52, 56, 58, 59 and 68 related cancer.
Consult us: info@hpvmedicalcenter.com.ar
(54-11) 4381 2009
Registros
1
a
1
de
1
Última actualización 2/5/2012 4:48:00 PM
Print



